Guided Project Congratulations

The guided project titled “Development of Novel CA IX-Targeted Hybrid Anticancer Molecules Based on a Docking Approach Using a Multi-Drug Single Target Strategy,” carried out within the Department of Pharmacy Services, has been accepted.

Within the scope of the project, computer-aided drug design and molecular modeling approaches will be employed to develop next-generation hybrid molecules targeting the CA IX enzyme in cancer therapy, with enhanced selectivity and efficacy. The project aims to expand research opportunities for students while contributing to the scientific literature and the development of local solutions in the field of health sciences.

We congratulate all academic staff involved in the project and wish them continued success in their work.